Transplant Cell Ther
Gastrointestinal DiseasesGastrointestinal MicrobiomeGraft vs Host Disease
Dr. Michael Verneris, MD
NPI1336240332
- Publications
- 180
- Clinical trials
- 8
- Industry payments
- $84,708
- Medical group
- 1
- State licenses
- 2
- Practice address
- 13123 E 16th Ave, Aurora, CO 80045
- Practice phone
- Call (720) 777-6126
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Children's Hospital Colorado
Aurora, Colorado
Find Dr. Verneris' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael Verneris is a pediatric hematology and oncology physician in Aurora, Colorado
Dr. Verneris practices at Children's Hospital Colorado in Aurora, Colorado.
Dr. Verneris' NPI, 1336240332, was assigned on September 25, 2006. Dr. Verneris holds Colorado license DR.0057740.
NPI and contact details
- NPI
- 1336240332NPI Registry (opens in a new tab)
- NPI enumeration date
- September 25, 2006
- NPI status
- Active
- Practice phone
- (720) 777-6126
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Michael Verneris practices at Children's Hospital Colorado in Aurora, Colorado
Dr. Verneris' primary practice is Children's Hospital Colorado, at 13123 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 777-6126.
- Children's Hospital Colorado13123 E 16th Ave, Aurora, CO 80045 · Adams CountyPhone(720) 777-6126
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Michael Verneris is affiliated with 1 site of care and 1 medical group
Dr. Verneris' primary practice is Children's Hospital Colorado in Aurora, Colorado. The medical group on file is University of Colorado Medicine (CU Medicine).
Children's Hospital ColoradoPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Michael Verneris' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Verneris practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Children's Hospital Colorado | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Verneris practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael Verneris is one of 69 pediatric hematologys and oncology physicians in Colorado
Pediatric hematology-oncology is Dr. Verneris' primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dmand AI has Dr. Verneris' licenses on file in 2 states: Colorado and Minnesota.
Specialties and state licenses
- Pediatric hematology and oncology, ColoradoPrimary
- Pediatrics, Minnesota
Pediatric hematologys and oncology physicians near Dr. Verneris
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
69pediatric hematologys and oncology physicians in Colorado50pediatric hematologys and oncology physicians in Aurora
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael Verneris' patients have a median age of 14
Across all payers, Dmand AI patient panel data puts Dr. Verneris' median patient age at 14, with 50% women.
Dr. Verneris' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 14
Patient panel by sex, all payers
- Women50%
- Men50%
Source: Dmand AI Patient Panel Data
Dr. Michael Verneris has 180 publications on record
Dmand AI links 180 papers to Dr. Verneris, published from 2003 to 2025. 2016 was the busiest year, with 21. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Killer Cells, Natural. Dr. Verneris has published most often in Biol Blood Marrow Transplant. Dr. Verneris' most frequent co-authors are John E. Wagner, MD, Bruce Robert Blazar, MD and Daniel J. Weisdorf, MD.
Papers180
Years published2003 to 2025
Dr. Verneris' papers by year, 2016 to 2025
Topics Dr. Verneris writes about most
- Hematopoietic Stem Cell Transplantation
- Graft vs Host Disease
- Killer Cells, Natural
- Transplantation Conditioning
- Transplantation, Homologous
- Hematologic Neoplasms
- Leukemia, Myeloid, Acute
- Cord Blood Stem Cell Transplantation
Dr. Verneris' most frequent co-authors
- John E. Wagner, MD35 shared papers
- Bruce Robert Blazar, MD34 shared papers
- Daniel J. Weisdorf, MD28 shared papers
Recent publications by Dr. Verneris
J Immunother Cancer
B7 AntigensCell Line, TumorImmunotherapy, Adoptive
Proc Natl Acad Sci U S A
Hematologic NeoplasmsHematopoietic Stem Cell TransplantationSocial Class
See who Dr. Verneris researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Verneris works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael Verneris has worked on 8 clinical trials
Dmand AI links Dr. Verneris to 8 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Mycoses, Adenoviridae Infections and Anemia, Refractory, with Excess of Blasts. Masonic Cancer Center, University of Minnesota sponsors the most, 4.
Clinical trials with Dr. Verneris by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Verneris' trials
- Mycoses
- Adenoviridae Infections
- Anemia, Refractory, with Excess of Blasts
- Burkitt Lymphoma
- Hepatoblastoma
Investigators on the most trials with Dr. Verneris
- Barbara Bambach, MD3 shared trials
- Christopher C. Dvorak, MD3 shared trials
- Christen L. Ebens, MD2 shared trials
Recent clinical trials with Dr. Verneris
Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES) PBMTC SUP1701 (opens in a new tab)
Active, not recruitingPhase 1/2
Adenoviridae InfectionsCytomegalovirus InfectionsVirus Specific T-cell (VST) infusion
HepatoblastomaRetinal NeoplasmsAnti-seizure prophylaxisAutologous stem cell infusionBusulfan
NeuroblastomaNeuroectodermal Tumors, Primitive, PeripheralAutologous stem cell infusionCarboplatinEtoposide
MT2013-37R: Voriconazole Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Patients (opens in a new tab)
CompletedPhase 1
MycosesBacterial Infections and MycosesVoriconazole
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant (opens in a new tab)
Active, not recruitingPhase 3
LymphomaLeukemiaLactobacillus plantarum strain 299Lactobacillus plantarum strain 299v
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael Verneris received $84,708 in industry payments from 2016 to 2025
CMS Open Payments shows 106 general payments to Dr. Verneris from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Novartis Pharmaceuticals Corporation paid the most, $42,595. It also lists 16 research payments totaling $11,037 from 2017 to 2020.
General payments to Dr. Verneris by program year, 2016 to 2025
General payments to Dr. Verneris by kind, 2016 to 2025
$84.7Kin total
- Consulting fees$61,48973%
- Speaker and faculty fees$10,35812%
- Travel and lodging$6,5058%
- Food and beverage$6,3568%
Companies that paid Dr. Verneris the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Michael Verneris's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael Verneris
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael Verneris' NPI number?
Dr. Michael Verneris' NPI number is 1336240332. It was assigned on September 25, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael Verneris?
Dr. Michael Verneris is a pediatric hematology and oncology physician in Aurora, Colorado. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Michael Verneris practice?
Dr. Verneris practices at 13123 E 16th Ave, Aurora, CO 80045. Dr. Verneris' primary practice is Children's Hospital Colorado in Aurora, Colorado.
What is Dr. Michael Verneris' office phone number?
The practice phone on file for Dr. Verneris is (720) 777-6126.
What is Dr. Michael Verneris' medical license number?
Dr. Verneris holds Colorado license DR.0057740, one of the licenses on file in 2 states.
Which states has Dr. Michael Verneris been licensed in?
Dmand AI has state licenses on file for Dr. Verneris in Colorado and Minnesota.
What medical group is Dr. Michael Verneris part of?
Dr. Verneris is linked to University of Colorado Medicine (CU Medicine).
Has Dr. Michael Verneris received payments from drug or device companies?
CMS Open Payments shows $84,708 in general payments to Dr. Verneris from 13 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Michael Verneris been practicing?
Dr. Verneris' NPI was assigned in 2006.
Does Dr. Michael Verneris do research?
Dmand AI links 180 publications to Dr. Verneris, published from 2003 to 2025. Dr. Verneris has worked on 8 clinical trials.
Who does Dr. Michael Verneris publish with?
Dr. Verneris' most frequent co-authors are John E. Wagner, MD (35 shared papers), Bruce Robert Blazar, MD (34 shared papers) and Daniel J. Weisdorf, MD (28 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Colorado by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card